Related Experiment Video
Updated: Dec 26, 2025

Author Spotlight: Flow Cytometric Determination of Pyroptosis in Avian Cells
Published on: May 31, 2024
Mechanism and regulation of pyroptosis-mediated in cancer cell death
Jianwei Ruan1, Shijian Wang1, Jiabing Wang1
1Municipal Hospital Affiliated to Medical School of Taizhou University, Taizhou, 318000, China.
Abstract:
Pyroptosis, a form of programmed cell death, has garnered increasing attention as it relates to innate immunity and diseases. The discovery of caspase-1/3/4/5/8/11 function in sensing various challenges expands the spectrum of pyroptosis mediators and also reveals that pyroptosis is not cell type specific. Recent studies have identified that pyroptosis has become a new topic in cancer research because it may affect all stages of carcinogenesis. In this mini-review, we provided a primer on pyroptosis, discussed the induction of pyroptosis in cancer and its implications in cancer management. Moreover, its two important executioners, the gasdermin D (GSDMD) and gasdermin E (GSDME), the functions and mechanisms of them involved in the regulation of cancer therapy were focused on. Small molecules-mediated pyroptosis were found to effectively inhibit various tumor cells. In brief, the findings of pyroptosis-dependent cancer progression, new drugs and therapeutic targets may lead to a promising, novel therapeutic approach for cancer patients.
Insights
Pyroptosis, a programmed cell death, is crucial in immunity and disease. Targeting pyroptosis, especially via gasdermin effectors, offers a promising new avenue for effective cancer therapy and treatment.
Area of Science:
- Immunology
- Cell Biology
- Oncology
Background:
- Pyroptosis is a key form of programmed cell death linked to innate immunity and various diseases.
- Its role in sensing cellular challenges is mediated by caspases, indicating it is not cell-type specific.
- Emerging research highlights pyroptosis's significance across all stages of carcinogenesis, making it a novel cancer research topic.
Purpose of the Study:
- To provide a foundational understanding of pyroptosis.
- To explore pyroptosis induction in cancer and its therapeutic implications.
- To focus on gasdermin D (GSDMD) and gasdermin E (GSDME) as key pyroptosis executioners in cancer therapy.
Main Methods:
- Literature review of pyroptosis mechanisms and roles in cancer.
- Analysis of caspase functions in pyroptosis induction.
- Examination of gasdermin family proteins (GSDMD, GSDME) in cancer regulation.
- Review of small molecule-induced pyroptosis in tumor cells.
Main Results:
- Pyroptosis mediators, including caspases, are diverse and not restricted to specific cell types.
- Pyroptosis influences all phases of cancer development and progression.
- Gasdermin D and E play critical roles in regulating cancer therapy outcomes.
- Small molecules inducing pyroptosis demonstrate significant efficacy against various tumor cells.
Conclusions:
- Pyroptosis is a critical cellular process with implications for innate immunity and disease pathology.
- Targeting pyroptosis, particularly its gasdermin-mediated pathways, presents a novel therapeutic strategy for cancer.
- Further research into pyroptosis-dependent cancer progression and therapeutic targets could yield promising treatments for cancer patients.
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Apoptosis
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...

